More about

Ldl Cholesterol

News
January 26, 2023
2 min read
Save

Lectin-like oxidized LDL receptor-1 inhibition safe in patients with diabetes

Lectin-like oxidized LDL receptor-1 inhibition safe in patients with diabetes

A novel agent demonstrated a dose-dependent relationship with lectin-like oxidized LDL receptor-1 suppression, a mechanism to lower inflammatory and lipid risk, and was well tolerated in a small study of patients with type 2 diabetes.

News
January 12, 2023
1 min read
Save

School-based food-related intervention confers LDL, HbA1c reductions in children

School-based food-related intervention confers LDL, HbA1c reductions in children

A school-based nutrition, gardening and cooking intervention was associated with reductions in LDL and HbA1c in children who participated, researchers reported in JAMA Network Open.

News
December 16, 2022
1 min read
Save

SPORT

SPORT

Low-dose statin therapy vs. placebo and six over-the-counter supplements marketed for cholesterol health.

News
December 02, 2022
2 min read
Save

Long-term PCSK9 inhibition plus background therapy improves LDL goal attainment in FH

Long-term PCSK9 inhibition plus background therapy improves LDL goal attainment in FH

Long-term adherence to PCSK9 inhibition was high among a high-risk cohort with familial hypercholesterolemia, which improved LDL goal attainment when added on top of background statin therapy and ezetimibe, researchers reported.

News
November 21, 2022
3 min read
Save

Risk prediction from low HDL varies by race

Risk prediction from low HDL varies by race

Low HDL was associated with CHD risk among white adults but not Black adults, and high HDL was not protective of risk in either, researchers reported.

News
November 16, 2022
2 min read
Save

Remote BP, cholesterol management program may optimize guideline-directed therapy

Remote BP, cholesterol management program may optimize guideline-directed therapy

An all-remote hypertension and hypercholesterolemia management program with more than 10,000 participants was associated with significant decreases in BP and LDL at 6 and 12 months compared with education only, researchers reported.

News
November 11, 2022
2 min read
Save

Inclisiran safely reduces LDL by 45% over 4 years: ORION-3

Inclisiran safely reduces LDL by 45% over 4 years: ORION-3

CHICAGO — In adults with atherosclerotic CVD or a risk equivalent, twice-yearly inclisiran injections were associated with a 44% reduction in LDL that was sustained over 4 years with no new safety signals observed, researchers reported.

CME
Video

Optimizing Lipid Lowering Therapy in Women: Gaps Perspectives and Advances

Optimizing Lipid Lowering Therapy in Women: Gaps Perspectives and Advances
0.75 CME
0.75 ANCC
45 MINS
$0 FEE
News
November 06, 2022
3 min read
Save

Statin therapy ‘vastly superior’ to common dietary supplements for cholesterol lowering

Statin therapy ‘vastly superior’ to common dietary supplements for cholesterol lowering

CHICAGO — Daily rosuvastatin lowered LDL, total cholesterol and serum triglycerides significantly more than placebo and six common over-the-counter dietary supplements, with no supplement lowering LDL more than placebo, researchers reported.

News
October 28, 2022
8 min read
Save

New guidance for clinicians offers advice on use of nonstatin therapies

New guidance for clinicians offers advice on use of nonstatin therapies

LDL reduction is the major focus in the primary and secondary prevention of atherosclerotic CVD.

View more